DK157340C - Fremgangsmaade til fremstilling af et pancreatisk glucagonspecifikt antistof - Google Patents

Fremgangsmaade til fremstilling af et pancreatisk glucagonspecifikt antistof

Info

Publication number
DK157340C
DK157340C DK059778A DK59778A DK157340C DK 157340 C DK157340 C DK 157340C DK 059778 A DK059778 A DK 059778A DK 59778 A DK59778 A DK 59778A DK 157340 C DK157340 C DK 157340C
Authority
DK
Denmark
Prior art keywords
procedure
preparation
specific antibody
pancreatic glucagon
glucagon specific
Prior art date
Application number
DK059778A
Other languages
Danish (da)
English (en)
Other versions
DK59778A (da
DK157340B (da
Inventor
Tomoyoshi Nishino
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of DK59778A publication Critical patent/DK59778A/da
Publication of DK157340B publication Critical patent/DK157340B/da
Application granted granted Critical
Publication of DK157340C publication Critical patent/DK157340C/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK059778A 1977-02-10 1978-02-09 Fremgangsmaade til fremstilling af et pancreatisk glucagonspecifikt antistof DK157340C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP52013919A JPS5836308B2 (ja) 1977-02-10 1977-02-10 抗体の製造方法
JP1391977 1977-02-10

Publications (3)

Publication Number Publication Date
DK59778A DK59778A (da) 1978-08-11
DK157340B DK157340B (da) 1989-12-18
DK157340C true DK157340C (da) 1990-05-14

Family

ID=11846569

Family Applications (1)

Application Number Title Priority Date Filing Date
DK059778A DK157340C (da) 1977-02-10 1978-02-09 Fremgangsmaade til fremstilling af et pancreatisk glucagonspecifikt antistof

Country Status (8)

Country Link
US (2) US4221777A (el)
JP (1) JPS5836308B2 (el)
BE (1) BE863810A (el)
DE (1) DE2805663B2 (el)
DK (1) DK157340C (el)
FR (1) FR2380296A1 (el)
GB (1) GB1580582A (el)
SE (1) SE427931B (el)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5539702A (en) * 1978-08-30 1980-03-19 Takeda Chem Ind Ltd Method of measuring enzyme immunity of pancreas glucagon
JPS5657753A (en) * 1979-10-16 1981-05-20 Toyo Jozo Co Ltd Novel glucagon fragment, and its use
US4376765A (en) * 1980-03-31 1983-03-15 Institut International De Pathologie Cellulaire Et Moleculaire Medicaments, their preparation and compositions containing same
JPS56163456A (en) * 1980-05-21 1981-12-16 Otsuka Pharmaceut Co Ltd Preparation of antigen
DK283180A (da) * 1980-07-01 1982-01-02 Novo Industri As Polypeptider og derivater deraf
JPS5735551A (en) * 1980-08-08 1982-02-26 Daiichi Rajio Isotope Kenkyusho:Kk Preparation of undecapeptide
US4430326A (en) 1981-12-22 1984-02-07 University Patents, Inc. Method of diminishing glucose levels resulting from endogenous glucagon
FR2525592B1 (el) * 1982-04-26 1984-09-14 Pasteur Institut
US4487715A (en) * 1982-07-09 1984-12-11 The Regents Of The University Of California Method of conjugating oligopeptides
US4591552A (en) * 1982-09-29 1986-05-27 New York Blood Center, Inc. Detection of hepatitis B surface antigen (or antibody to same) with labeled synthetic peptide
EP0134868A1 (en) * 1983-08-26 1985-03-27 Anda Biologicals Unicellular organisms activated by glutaraldehyde as solid carriers for sensitizing agents and uses of sensitized unicellular organisms
CA1256795A (en) * 1983-12-28 1989-07-04 Dennis A. Carson Anti-idiotype antibodies induced by synthetic polypeptides
US4666884A (en) * 1984-04-10 1987-05-19 New England Deaconess Hospital Method of inhibiting binding of von Willebrand factor to human platelets and inducing interaction of platelets with vessel walls
US4617376A (en) * 1985-07-01 1986-10-14 Eli Lilly And Company Process for recovering glucagon from pancreas glands
US4731439A (en) * 1985-11-22 1988-03-15 Oncogen Snake venom growth arresting peptide
US5545618A (en) * 1990-01-24 1996-08-13 Buckley; Douglas I. GLP-1 analogs useful for diabetes treatment
US5253736A (en) * 1991-08-01 1993-10-19 Tec Tran Corporation Railway brake actuator
US5176227A (en) * 1991-08-01 1993-01-05 Tec Tran Corporation Railway service and parking brake actuator
US20050009205A1 (en) * 2003-07-11 2005-01-13 Ye Fang Fluorescent ligands for GPCR arrays
EP3194441A1 (en) 2014-09-16 2017-07-26 Regeneron Pharmaceuticals, Inc. Anti-glucagon antibodies and uses thereof
MA46089A (fr) 2016-08-30 2019-07-10 Regeneron Pharma Procédés de traitement de la résistance à l'insuline grave par interférence avec la signalisation du récepteur du glucagon
EP3529278A1 (en) 2016-10-20 2019-08-28 Regeneron Pharmaceuticals, Inc. Methods of lowering blood glucose levels
JP2020531532A (ja) 2017-08-22 2020-11-05 リジェネロン・ファーマシューティカルズ・インコーポレイテッド グルカゴン受容体シグナル伝達に干渉することによって尿素サイクル異常症を治療する方法
CN114410590B (zh) * 2022-01-27 2024-01-09 广州市进德生物科技有限公司 一种分泌胰高血糖素单克隆抗体杂交瘤细胞株及其单克隆抗体与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3553310A (en) * 1967-12-28 1971-01-05 Miles Lab Immunologically reactive particles
CH453269A4 (el) * 1968-03-29 1973-01-31
GB1282163A (en) * 1969-08-06 1972-07-19 Beecham Group Ltd Modified allergens and a process for their preparation
US3975342A (en) * 1972-05-15 1976-08-17 Biological Developments, Inc. Tyrosyl-class antigenic conjugates, their preparation and antibodies raised thereto
US3996345A (en) * 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4075194A (en) * 1976-12-09 1978-02-21 Yeda Research And Development Co., Ltd. Novel synthetic undecapeptide and clinical assay

Also Published As

Publication number Publication date
BE863810A (fr) 1978-05-29
JPS5836308B2 (ja) 1983-08-08
FR2380296B1 (el) 1981-07-10
GB1580582A (en) 1980-12-03
JPS5399320A (en) 1978-08-30
DE2805663C3 (el) 1980-11-13
DK59778A (da) 1978-08-11
DE2805663A1 (de) 1978-08-17
FR2380296A1 (fr) 1978-09-08
DE2805663B2 (de) 1980-03-13
SE427931B (sv) 1983-05-24
DK157340B (da) 1989-12-18
US4272433A (en) 1981-06-09
US4221777A (en) 1980-09-09
SE7801545L (sv) 1978-08-11

Similar Documents

Publication Publication Date Title
DK157340C (da) Fremgangsmaade til fremstilling af et pancreatisk glucagonspecifikt antistof
DK151931C (da) Fremgangsmaade til fremstilling af et farmacentisk praeparat i enhedsdosisform
DK113676A (da) Fremgangsmade til fremstilling af et retardpreparat
DK343581A (da) Fremgangsmaade til fremstilling af et triamterenpraeparat
DK110778A (da) Fremgangsmaade til fremstilling af 4-acylamino-phenyl-ethanolaminer
DK306978A (da) Fremgangsmaade til fremstilling af 1-acyl-2-cyanaziridiner
DK190478A (da) Fremgangsmaade til fremstilling af et kulturkoncentrat
DK152516C (da) Fremgangsmaade til propagering af rotavirus
DK247078A (da) Fremgangsmaade til fremstilling af et krystallinsk natrium-silicoaluminat
DK231578A (da) Fremgangsmaade til fremstilling af n-acetyl-p-aminophenyl-n!-acetyl-aminothioalkansyreesterderivater
DK527078A (da) Fremgangsmaade til fremstilling af et polysaccharid
DK145701C (da) Fremgangsmaade til fremstilling af ergotalkaloider
DK151078A (da) Fremgangsmaade til fremstilling af cyclobutanoner
DK237978A (da) Fremgangsmaade til fremstilling af alfafluormethyl-alfa-aminoalkansyrer
DK352578A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat
DK154949C (da) Fremgangsmaade til fremstilling af trifluormethylphenoler
DK471181A (da) Fremgangsmaade til fremstilling af et pyrimidinderivat
DK102978A (da) Fremgangsmaade til fremstilling af et fast steroidpraeparat
DK31478A (da) Fremgangsmaade til fremstilling af aralkylaniliner
DK364578A (da) Fremgangsmaade til fremstilling af hydroxyphenylhydantoin
DK164878A (da) Fremgangsmaade til fremstilling af monochlorpinakolin
DK248978A (da) Fremgangsmaade til fremstilling af hydroxy-alfa-aminobenzylpenicillin
DK371477A (da) Fremgangsmaade til fremstilling af et praeparat
DK339777A (da) Fremgangsmaade til fremstilling af 2-benzylperhydroazepiner
DK83778A (da) Fremgangsmaade til fremstilling af arylhexafuranosider

Legal Events

Date Code Title Description
PUP Patent expired